HomeCompareBERY vs MRK

BERY vs MRK: Dividend Comparison 2026

BERY yields 1.70% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $35.6K in total portfolio value
10 years
BERY
BERY
● Live price
1.70%
Share price
$67.58
Annual div
$1.15
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.1K
Annual income
$189.54
Full BERY calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — BERY vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBERYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BERY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BERY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BERY
Annual income on $10K today (after 15% tax)
$144.33/yr
After 10yr DRIP, annual income (after tax)
$161.11/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, MRK beats the other by $8,435.60/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BERY + MRK for your $10,000?

BERY: 50%MRK: 50%
100% MRK50/50100% BERY
Portfolio after 10yr
$39.9K
Annual income
$5,151.66/yr
Blended yield
12.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

BERY
Analyst Ratings
13
Buy
8
Hold
Consensus: Buy
Price Target
$72.75
+7.7% upside vs current
Range: $62.00 — $84.00
Altman Z
1.7
Piotroski
8/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BERY buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBERYMRK
Forward yield1.70%2.81%
Annual dividend / share$1.15$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$22.1K$57.7K
Annual income after 10y$189.54$10,113.78
Total dividends collected$1.8K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$72.75$128.54

Year-by-year: BERY vs MRK ($10,000, DRIP)

YearBERY PortfolioBERY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,870$169.80$11,213$373.04$343.00MRK
2$11,803$172.50$12,667$512.06$864.00MRK
3$12,804$175.06$14,439$708.14$1.6KMRK
4$13,878$177.48$16,640$988.16$2.8KMRK
5$15,030$179.78$19,432$1,394.07$4.4KMRK
6$16,264$181.96$23,057$1,992.90$6.8KMRK
7$17,586$184.02$27,889$2,894.79$10.3KMRK
8$19,003$185.96$34,518$4,286.29$15.5KMRK
9$20,521$187.80$43,912$6,494.35$23.4KMRK
10$22,147$189.54$57,714$10,113.78$35.6KMRK

BERY vs MRK: Complete Analysis 2026

BERYStock

Berry Global Group, Inc. manufactures and supplies non-woven, flexible, and rigid products in consumer and industrial end markets. The company operates through Consumer Packaging International; Consumer Packaging North America; Engineered Materials; and Health, Hygiene & Specialties segments. The Consumer Packaging International segment offers closures and dispensing systems, pharmaceutical devices and packaging, bottles and canisters, containers, and technical components. The Consumer Packaging North America segment provides containers and pails, foodservice products, closures and overcaps, bottles and prescription vials, and tubes. The Engineered Materials segment offers stretch and shrink, converter, food and consumer, and agriculture films, as well as institutional can liners and retail bags. The Health, Hygiene & Specialties segment provides healthcare, hygiene, specialties, and tapes. Berry Global Group, Inc. sells its products through direct sales force of professionals and distributors in the United States, Canada, Europe, and internationally. The company was formerly known as Berry Plastics Group, Inc. and changed its name to Berry Global Group, Inc. in April 2017. Berry Global Group, Inc. was founded in 1967 and is based in Evansville, Indiana.

Full BERY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this BERY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BERY vs SCHDBERY vs JEPIBERY vs OBERY vs KOBERY vs MAINBERY vs JNJBERY vs ABBVBERY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.